Follistim-AQ “not approvable”
Executive Summary
Organon will meet with FDA in the next few weeks to discuss "not approvable" letter for Follistim-AQ Cartridge, the ready-to-use version of the fertility product follitropin. FDA requested more data...
You may also be interested in...
Organon Follistim Sales Aid Cited For Misleading Cost-Effectiveness Claims
An Organon sales brochure for the infertility agent Follistim makes misleading cost-effectiveness claims, FDA's Division of Drug Manufacturing, Advertising & Communications said in a Dec. 12 letter
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.